Enverse is comprised of dehydrated human amniotic membrane obtained from donated placental tissue.
INTENDED USE: Enverse contains non-viable cells and is to be used as a wound covering or barrier membrane, over chronic and acute wounds, including dermal ulcers or defects.
CLAIMED BENEFITS: No viable or non-viable cells are added to the harvested amniotic membrane. The processed membrane is dehydrated and cut into various sizes, and presented in a sterilized, dehydrated sheet graft form. Contains collagen and hyaluronic acid. Protective, resorbable wound covering. Translucent for increased application site visibility. Compact for shallow tissue defects.
OPTION: Enverse is packaged as individual sheets in a range of sizes; each sheet is presented in a configuration for various applications. Enverse is for single patient use only. The amount of Enverse used will be determined by the treating health care provider based on the size of the wound. Enverse can be applied over the wound area either wet or dry. If hydration is preferred, sterile solution is used to hydrate the graft after placement on the wound site. Enverse should be maintained in its original packaging and stored at ambient temperature (0°C to 38°C) until ready to use. When stored properly in their original packaging, Enverse allografts are shelf-stable.
EN-0015: Enverse, 15mm, Sheet Format: Q4258
EN-2030: Enverse, 2x3 cm, Sheet Format: Q4258
EN-4040: Enverse, 4x4 cm, Sheet Format: Q4258
EN-4060: Enverse, 4x6 cm, Sheet Format: Q4258
EN-6080: Enverse, 6x8 cm, Sheet Format: Q4258
Wound Reference does not produce, market, re-sell or distribute health care goods or services consumed by, or used on, patients.
